News

C-section Hysterectomy Clinical trial Interventional Radiology Balloon Catheter

Using tiny balloons to temporarily block blood flow to the uterus during a high-risk Caesarean-section delivery can save the life of the mother while preventing hysterectomy and preserving...

December 26, 2012 — Covidien announced a definitive agreement to acquire CV Ingenuity. The companies expect to complete the acquisition in the first calendar quarter of 2013. Financial...

Primus Drug-Eluting Balloon Balloon Catheters Peripheral Artery Disease devices

November 1, 2012 — It looks as though drug-eluting balloons (DEBs), already widely used in Europe, are set to burst...

AngioDynamics Vortex Medical Inc.Thrombectomy devices

AngioDynamics said it entered into a definitive agreement to acquire all the outstanding capital stock of Vortex Medical Inc., a privately held company focused on the development of innovative...

September 28, 2012 — Boston Scientific Corp. announced it has received U.S. Food and Drug Administration (FDA) clearance for the Emerge percutaneous transluminal coronary angioplasty (PTCA)...

September 21, 2012 — Following the success of Biotronik’s Pulsar-18 0.018-inch, 4 French platform self-expanding...

July 27, 2012 — C. R. Bard Inc. announced that its Lutonix technology center has completed patient enrollment into its global, multicenter LEVANT 2 randomized clinical trial.

July 16, 2012 — TriReme Medical Inc. (TMI) announced today that it has received U.S. Food and Drug Administration (FDA) clearance for an expanded matrix of sizes for its unique Glider PTCA balloon...

July 9, 2012 — r4 Vascular Inc. announced clearance from the U.S. Food and Drug Administration (FDA) to market the Vector percutaneous transluminal angioplasty (PTA)...

July 9, 2012 — Miracor Medical Systems GmbH announced that the first three ST segment elevation myocardial infarction (STEMI) patients enrolled in its “Prepare RAMSES” ...

June 21, 2012 — TriReme Medical Inc. (TMI) announced today that it has received U.S. Food and Drug Administration (FDA) clearance for an expanded matrix of sizes for its Chocolate percutaneous...

June 13, 2012 — Physicians presented at EuroPCR 2012 the results of two multicenter, randomized controlled trials, the BELLO and PACIFIER studies, each one showing statistically significant...

May 30, 2012— Boston Scientific Corp. announces the U.S. Food and Drug Administration has cleared an expanded use indication for the CRE Wireguided Balloon Dilator for endoscopic dilation of the...

May 23, 2012 - TriReme Medical Inc. announced approval by the U.S. Food and Drug Administration (FDA) of the Glider PTCA Catheter, indicated for treating the stenotic portion of coronary arteries...

May 4, 2012 - Angioslide Ltd., a provider of embolic capture angioplasty solutions, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its new 3x100 mm...

May 4, 2012 - A new balloon catheter system could advance the endovascular approach to treating obstructed...

April 24, 2012 - Boston Scientific Corp. announces CE mark and European market launch of the Emerge PTCA Dilatation Catheter. The Emerge catheter is a next-generation pre-dilatation balloon...

January 25, 2012 — Physicians at University Hospitals (UH) Case Medical Center enrolled their first patient in LEVANT 2, a global, multicenter, randomized clinical trial evaluating the safety and...

December 15, 2011 — Neovasc Inc. announced it has received the CE mark designation for its Reducer product for the treatment of refractory angina. CE marking confirms the Reducer conforms to...

December 13, 2011 – Boston Scientific announced the U.S. launch of its Charger PTA Balloon Catheter, a 0.035-inch percutaneous transluminal angioplasty (PTA) balloon catheter designed for a wide...